Clinically silent idiopathic Parkinson’s disease unmasked by valproate use: a brief report

Aging Clinical and Experimental Research

Volumn 27, Issue 3, 2015, Pages 387-390

  Athauda, Dilan ^a   Batley, Robert ^b   Ellis, Catherine ^a  

^a MEDWAY MARITIME HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Epilepsy; Parkinsonism; Valproate

Indexed keywords

CARBIDOPA PLUS LEVODOPA; VALPROIC ACID;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; HUMAN; IDIOPATHIC DISEASE; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; SEIZURE; CHEMICALLY INDUCED;

PARKINSONIA;

AGED; HUMANS; MALE; PARKINSON DISEASE, SECONDARY; VALPROIC ACID;

EID: 84929160806     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-014-0278-z     Document Type: Article

References (7)

1. Macphee GJ, Stewart DA (2007) Diagnosis of Parkinsonism in older patients receiving sodium valproate. Mov Disord 22:1211
2. Mahmoud F, Tampi RR (2011) Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature. Am J Geriatr Pharmacother 9:405–412
3. López-Sendón JL, Mena MA, de Yébenes JG (2012) Drug-induced parkinsonism in the elderly: incidence, management and prevention. Drugs Aging 29(2):105–118
4. Brigo F, Erro R, Marangi A et al (2014) Differentiating drug-induced parkinsonism from Parkinson’s disease: an update on non-motor symptoms and investigations. Parkinsonism Relat Disord 20:808–814
5. Silver M, Factor S (2013) Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia. Parkinsonism Relat Disord 19:758–760
6. López-Sendón J, Mena MA, de Yébenes JG (2013) Drug-induced parkinsonism. Expert Opin Drug Saf 12:487–496
7. Evans M, Shinar R, Yaari R (2011) Reversible dementia and gait disturbance after prolonged use of valproic acid. Seizure 20:509–511